These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 31241229)

  • 21. Effects of isotretinoin therapy on lipoprotein (a) serum levels.
    Georgala S; Schulpis KH; Potouridou I; Papadogeorgaki H
    Int J Dermatol; 1997 Nov; 36(11):863-4. PubMed ID: 9427083
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A population-based analysis of laboratory abnormalities during isotretinoin therapy for acne vulgaris.
    Zane LT; Leyden WA; Marqueling AL; Manos MM
    Arch Dermatol; 2006 Aug; 142(8):1016-22. PubMed ID: 16924051
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Abnormal Baseline Lab Results Rarely Lead to Treatment Modification for Patients on Isotretinoin.
    Tkachenko E; Sharma P; Mostaghimi A
    Dermatology; 2020; 236(6):517-520. PubMed ID: 32069457
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A pilot study evaluating anxiety and depressive scores in acne patients treated with isotretinoin.
    Ferahbas A; Turan MT; Esel E; Utas S; Kutlugun C; Kilic CG
    J Dermatolog Treat; 2004 Jun; 15(3):153-7. PubMed ID: 15204147
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spurious elevation of aspartate aminotransferase in a patient on isotretinoin.
    Duffy EK; Bales CB; Carlow DC; Treat JR
    J Am Acad Dermatol; 2014 Oct; 71(4):e132-3. PubMed ID: 25219729
    [No Abstract]   [Full Text] [Related]  

  • 26. Evaluation of the effect of isotretinoin on salivary gland function by Tc-99m pertechnetate imaging in acne vulgaris patients.
    Örsal E; Seven B; Erdem MT; Varoğlu E; Farimaz H; Ayan AK
    Turk J Med Sci; 2015; 45(3):674-7. PubMed ID: 26281338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of serum transaminases with short- and long-term outcomes in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Gao M; Cheng Y; Zheng Y; Zhang W; Wang L; Qin L
    BMC Cardiovasc Disord; 2017 Jan; 17(1):43. PubMed ID: 28129742
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of different doses of isotretinoin treatment on the levels of serum homocysteine, vitamin B 12 and folic acid in patients with acne vulgaris: A prospective controlled study.
    Kamal M; Polat M
    J Pak Med Assoc; 2015 Sep; 65(9):950-3. PubMed ID: 26338739
    [TBL] [Abstract][Full Text] [Related]  

  • 29. L-carnitine supplementation in patients with cystic acne on isotretinoin therapy.
    Georgala S; Schulpis KH; Georgala C; Michas T
    J Eur Acad Dermatol Venereol; 1999 Nov; 13(3):205-9. PubMed ID: 10642057
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An observational study of isotretinoin recipients treated for acne in a health maintenance organization.
    McElwee NE; Schumacher MC; Johnson SC; Weir TW; Greene SL; Scotvold MJ; Hunter JR; Dinan BJ; Jick H
    Arch Dermatol; 1991 Mar; 127(3):341-6. PubMed ID: 1825596
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dietary Supplements, Isotretinoin, and Liver Toxicity in Adolescents: A Retrospective Case Series.
    DeKlotz CMC; Roby KD; Friedlander SF
    Pediatrics; 2017 Oct; 140(4):. PubMed ID: 28864554
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is mean platelet volume an inflammatory marker in acne patients treated with isotretinoin?
    Tamer F; Yuksel ME; Avcı E
    Acta Dermatovenerol Alp Pannonica Adriat; 2019 Jun; 28(2):65-69. PubMed ID: 31233169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isotretinoin treatment reduces acne lesions but not directly lesional acne inflammation.
    Kelhälä HL; Fyhrquist N; Palatsi R; Lehtimäki S; Väyrynen JP; Kubin ME; Kallioinen M; Alenius H; Tasanen K; Lauerma A
    Exp Dermatol; 2016 Jun; 25(6):477-8. PubMed ID: 26845242
    [No Abstract]   [Full Text] [Related]  

  • 34. [Differential liver histopathological features of chronic HBV infection patients with normal and mildly elevated serum ALT].
    Ying RS; Yang Z; Chen YY; Yang KL; Xiao YH; Wu LJ; Fan HM
    Zhonghua Gan Zang Bing Za Zhi; 2012 Aug; 20(8):585-8. PubMed ID: 23207151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decreased plasma folate concentration in young and elderly healthy subjects after a short-term supplementation with isotretinoin.
    Chanson A; Cardinault N; Rock E; Martin JF; Souteyrand P; D'Incan M; Brachet P
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):94-100. PubMed ID: 18181979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of clinical adverse effects and laboratory alterations in patients with acne vulgaris treated with oral isotretinoin.
    Brito Mde F; Sant'Anna IP; Galindo JC; Rosendo LH; Santos JB
    An Bras Dermatol; 2010; 85(3):331-7. PubMed ID: 20676466
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bone mineral density and bone turnover markers in patients receiving a single course of isotretinoin for nodulocystic acne.
    Tekin NS; Ozdolap S; Sarikaya S; Keskin SI
    Int J Dermatol; 2008 Jun; 47(6):622-5. PubMed ID: 18477161
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum lipid elevation during isotretinoin therapy for acne in the west of Scotland.
    Walker BR; MacKie RM
    Br J Dermatol; 1990 Apr; 122(4):531-7. PubMed ID: 2140047
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Laboratory Monitoring During Isotretinoin Therapy for Acne: A Systematic Review and Meta-analysis.
    Lee YH; Scharnitz TP; Muscat J; Chen A; Gupta-Elera G; Kirby JS
    JAMA Dermatol; 2016 Jan; 152(1):35-44. PubMed ID: 26630323
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systemic isotretinoin has an impact on hemoglobin, ferritin, urea, ceruloplasmin, albumin, uric acid levels, and neutrophil to lymphocyte ratio in acne patients.
    Hareedy MS; Tawfik KM
    J Cosmet Dermatol; 2022 Nov; 21(11):6191-6198. PubMed ID: 35770307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.